Frankfurt
09.01.26 | 08:05
0,068 Euro
-3,55 % -0,003
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,070 | 0,095 | 19:08 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| Do | Ventripoint Diagnostics Ltd (2): Ventripoint increases financing to $1-million | 2 | Stockwatch | ||
| Mi | Ventripoint Diagnostics Ltd.: Ventripoint Doubles the Size of Private Placement Due to Strong Investor Demand | 1 | TheNewswire | ||
| 30.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint Announces Non-Brokered Units Private Placement | 1 | TheNewswire | ||
| VENTRIPOINT DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 18.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Collaboration with Summit Sciences | 1 | TheNewswire | ||
| 18.12.25 | Ventripoint Diagnostics Ltd (2): Ventripoint to issue 1.1M shares for debenture interest | 1 | Stockwatch | ||
| 18.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint to Issue Shares for Payment of Debenture Interest | 1 | TheNewswire | ||
| 16.12.25 | Ventripoint Diagnostics Ltd (2): Ventripoint $567,000 debenture private placement | 1 | Stockwatch | ||
| 12.12.25 | Stocks in Play: Ventripoint Diagnostics Ltd | 1 | Baystreet.ca | ||
| 12.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint Unveils a Global Model for A.I.-Enhanced Heart Care through Partnership with the Nisga'a Valley Health Authority | 1 | TheNewswire | ||
| 03.12.25 | Ventripoint Diagnostics Ltd (2): Ventripoint appoints Swetlow as CFO | 1 | Stockwatch | ||
| 03.12.25 | Ventripoint Diagnostics appoints David Swetlow as CFO | 1 | Seeking Alpha | ||
| 03.12.25 | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics Announces Appointment of David Swetlow as Chief Financial Officer | 2 | TheNewswire | ||
| 27.11.25 | CEO.CA Technologies Ltd.: CEO.CA's Inside the Boardroom: Ventripoint Diagnostics: We Made Ultrasound as Good as MRI - Now Here's How We Scale It | 267 | Newsfile | Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - CEO.CA ("CEO.CA"), the leading investor social network in junior resource and venture stocks, shares exclusive updates with CEOs of junior mining... ► Artikel lesen | |
| 07.11.25 | Ventripoint Diagnostics Ltd (2): Ventripoint arranges $542,591 debt settlement | 1 | Stockwatch | ||
| 06.11.25 | Ventripoint Diagnostics Ltd.: Ventripoint Announces Debt Settlement Agreements | 2 | TheNewswire | ||
| 29.10.25 | Ventripoint Diagnostics Ltd (2): Ventripoint to test AI-enhanced echocardiography | 1 | Stockwatch | ||
| 29.10.25 | Ventripoint Diagnostics Ltd.: Ventripoint Diagnostics and Providence Health Care Ventures Announce Collaboration to Validate AI-Enabled Cardiac Imaging at St. Paul's Hospital | 1 | TheNewswire | ||
| 24.10.25 | Ventripoint Diagnostics Ltd (2): Ventripoint talks VMS+, sales expansion, partnerships | 2 | Stockwatch | ||
| 24.10.25 | Ventripoint Diagnostics Ltd.: Ventripoint Provides Corporate Update and Announces Shareholder Teleconference | 1 | TheNewswire |
1 2 Weiter >>
34 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 0,561 | -0,53 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| TANDEM DIABETES | 18,625 | -3,57 % | TANDEM DIABETES CARE INC - 8-K, Current Report | ||
| MOLINA HEALTHCARE | 155,40 | -1,33 % | Earnings Preview: What To Expect From Molina Healthcare's Report | ||
| VERU | 2,380 | +3,03 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 2,175 | -0,05 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen | |
| SEMLER SCIENTIFIC | 17,400 | -2,25 % | Strive, Inc. (Nasdaq: ASST) and Semler Scientific, Inc. (Nasdaq: SMLR) Announce Bitcoin Treasury Merger in All-Stock Transaction | DALLAS, TX and CAMPBELL, CA, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Strive, Inc. ("Strive") entered into a definitive agreement to acquire Semler Scientific, Inc. ("Semler Scientific") in an all-stock... ► Artikel lesen | |
| SOMNIGROUP INTERNATIONAL | 78,50 | -1,26 % | Somnigroup International: Somnigroup Proposes to Acquire Leggett & Platt in All-Stock Transaction | Proposal represents 30.3% premium to the average closing price of Leggett & Platt's shares during the last 30 trading days
Combination would provide Leggett &... ► Artikel lesen | |
| SHL TELEMEDICINE | - | - | Loyens & Loeff unterstützt SHL Telemedicine bei Kapitalerhöhung | ||
| SINTX TECHNOLOGIES | 3,730 | -2,61 % | SiNtx Technologies, Inc.: SINTX Technologies unterzeichnet Liefervertrag mit EVONIK zur Herstellung eines Siliziumnitrid-PEEK-Verbundwerkstoffes für KI-gestützte, 3D-gedruckte patientenspezifische Implantate | Ein Meilenstein, der die sofortige Produktion von maßgefertigten SiN/PEEK-Implantaten ermöglichtSALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX"... ► Artikel lesen | |
| NEURONETICS | 1,700 | +0,83 % | Neuronetics, Inc. - 8-K, Current Report | ||
| SIEMENS HEALTHINEERS | 46,510 | -0,04 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,500 | +1,26 % | EQS-Adhoc: Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort | EQS-Ad-hoc: Fresenius Medical Care AG / Schlagwort(e): Aktienrückkauf
Fresenius Medical Care AG: Fresenius Medical Care AG setzt Aktienrückkaufprogramm beschleunigt fort
09.01.2026... ► Artikel lesen | |
| FRESENIUS | 49,230 | -1,05 % | dpa-AFX-Überblick: UNTERNEHMEN vom 09.01.2026 - 15.15 Uhr | ROUNDUP: Teamviewer erreicht Umsatzziel für 2025 - Aktie mit Erholungsversuch GÖPPINGEN - Der Softwareanbieter Teamviewer hat 2025 sein im Herbst gesenktes Umsatzziel knapp erreicht. Basierend auf... ► Artikel lesen | |
| BETA BIONICS | 21,090 | -34,07 % | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 41,260 | -1,01 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen |
Das Unternehmen VENTRIPOINT DIAGNOSTICS LTD kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,068 Euro und damit -3,55 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VENTRIPOINT DIAGNOSTICS LTD finden Sie auf Wallstreet Online.